$343.22
2.21%
NYSE, Sep 05, 10:13 pm CET
ISIN
US92826C8394
Symbol
V

Visa Target price 2025 - Analyst rating & recommendation

Visa Classifications & Recommendation:

Buy
80%
Hold
20%

Visa Price Target

Target Price $408.00
Price $343.22
Potential 18.87%
Number of Estimates 38
38 Analysts have issued a price target Visa 2026 . The average Visa target price is $408.00. This is 18.87% higher than the current stock price. The highest price target is $446.25 30.02% , the lowest is $307.25 10.48% .
A rating was issued by 44 analysts: 35 Analysts recommend Visa to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Visa stock has an average upside potential 2026 of 18.87% . Most analysts recommend the Visa stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028


Sep '24 2025
Estimates
Revenue Billion $ 35.93 40.68
10.02% 13.23%
EBITDA Margin 69.84% 70.02%
0.28% 0.26%
Net Margin 54.16% 55.39%
4.09% 2.27%

39 Analysts have issued a sales forecast Visa 2025 . The average Visa sales estimate is $40.7b . This is 4.59% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $42.1b 8.19% , the lowest is $38.8b 0.22% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $35.9b 10.02%
2025 $40.7b 13.23%
2026 $45.1b 10.76%
2027 $49.6b 10.14%
2028 $54.1b 9.10%

29 Analysts have issued an Visa EBITDA forecast 2025. The average Visa EBITDA estimate is $28.5b . This is 5.34% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $29.7b 9.98% , the lowest is $25.6b 5.46% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $25.1b 9.71%
2025 $28.5b 13.53%
2026 $31.8b 11.64%
2027 $35.1b 10.49%
2028 $38.4b 9.26%
2029 $42.5b 10.77%

EBITDA Margin

2024 69.84% 0.28%
2025 70.02% 0.26%
2026 70.58% 0.80%
2027 70.81% 0.33%
2028 70.91% 0.14%

40 Visa Analysts have issued a net profit forecast 2025. The average Visa net profit estimate is $22.5b . This is 12.32% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $23.4b 16.84% , the lowest is $21.4b 6.78% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $19.5b 14.53%
2025 $22.5b 15.80%
2026 $25.3b 12.30%
2027 $28.6b 12.99%
2028 $32.6b 14.18%
2029 $36.9b 13.07%

Net Margin

2024 54.16% 4.09%
2025 55.39% 2.27%
2026 56.16% 1.39%
2027 57.61% 2.58%
2028 60.29% 4.65%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029


Sep '24 2025
Estimates
Earnings Per Share $ 9.58 11.67
17.69% 21.82%
P/E 29.41
EV/Sales 16.40

40 Analysts have issued a Visa forecast for earnings per share. The average Visa EPS is $11.67 . This is 13.85% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.14 18.44% , the lowest is $11.09 8.20% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $9.58 17.69%
2025 $11.67 21.82%
2026 $13.10 12.25%
2027 $14.81 13.05%
2028 $16.90 14.11%
2029 $19.11 13.08%

P/E ratio

Current 33.48 12.31%
2025 29.41 12.17%
2026 26.19 10.95%
2027 23.18 11.49%
2028 20.30 12.42%
2029 17.96 11.53%

Based on analysts' sales estimates for 2025, the Visa stock is valued at an EV/Sales of 16.40 and an P/S ratio of 16.26 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 17.15 8.89%
2025 16.40 4.36%
2026 14.81 9.71%
2027 13.45 9.21%
2028 12.32 8.34%

P/S ratio

Current 17.00 8.71%
2025 16.26 4.39%
2026 14.68 9.71%
2027 13.32 9.21%
2028 12.21 8.34%

Current Visa Upgrades & Downgrades

Analyst Rating Action Date
Macquarie
Outperform
Outperform
Unchanged Jul 31 2025
Barclays
Overweight
Overweight
Unchanged Jul 31 2025
Morgan Stanley
Overweight
Overweight
Unchanged Jul 30 2025
UBS
Buy
Buy
Unchanged Jul 30 2025
Truist Securities
Buy
Buy
Unchanged Jul 17 2025
Deutsche Bank
Buy
Unchanged Jul 17 2025
Oppenheimer
Outperform
Outperform
Unchanged Jul 02 2025
Analyst Rating Date
Unchanged
Macquarie:
Outperform
Outperform
Jul 31 2025
Unchanged
Barclays:
Overweight
Overweight
Jul 31 2025
Unchanged
Morgan Stanley:
Overweight
Overweight
Jul 30 2025
Unchanged
UBS:
Buy
Buy
Jul 30 2025
Unchanged
Truist Securities:
Buy
Buy
Jul 17 2025
Unchanged
Deutsche Bank:
Buy
Jul 17 2025
Unchanged
Oppenheimer:
Outperform
Outperform
Jul 02 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today